Prospects and challenges of CRISPR/Cas9 gene-editing technology in cancer research

被引：3
|
作者：
Ning, Li [1 ,2 ]
Xi, Jiahui [1 ,2 ]
Zi, Yin [1 ,2 ]
Chen, Min [1 ,2 ]
Zou, Qingjian [1 ,2 ]
Zhou, Xiaoqing [1 ,2 ]
Tang, Chengcheng [1 ,2 ]
机构：
[1] Wuyi Univ, South China Inst Large Anim Models Biomed, Sch Biotechnol & Hlth Sci, Guangdong Prov Key Lab Large Anim Models Biomed, Jiangmen 529000, Peoples R China
[2] Int Healthcare Innovat Inst Jiangmen, Jiangmen, Peoples R China
来源：
CLINICAL GENETICS | 2023年 / 104卷 / 06期
关键词：
cancer; gene-editing; CRISPR/Cas9; gene therapy; immunotherapy; T-CELLS; CAS9; RIBONUCLEOPROTEIN; GENOMIC DNA; DELIVERY; BASE; IDENTIFICATION; BACTERIA; EFFICACY; REPEATS; SYSTEMS;
D O I：
10.1111/cge.14424
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Cancer, one of the leading causes of death, usually commences and progresses as a result of a series of gene mutations and dysregulation of expression. With the development of clustered regularly interspaced palindromic repeat (CRISPR)/Cas9 gene-editing technology, it is possible to edit and then decode the functions of cancer-related gene mutations, markedly advance the research of biological mechanisms and treatment of cancer. This review summarizes the mechanism and development of CRISPR/Cas9 gene-editing technology in recent years and describes its potential application in cancer-related research, such as the establishment of human tumor disease models, gene therapy and immunotherapy. The challenges and future development directions are highlighted to provide a reference for exploring pathological mechanisms and potential treatment protocols of cancer.
引用
收藏
页码：613 / 624
页数：12
相关论文
共 50 条
  • [31] CRISPR/Cas9-based gene-editing technology for sickle cell disease
    Ma, Liangliang
    Yang, Shanglun
    Peng, Qianya
    Zhang, Jingping
    Zhang, Jing
    GENE, 2023, 874
  • [32] Genome editing (CRISPR/Cas9) in plant disease management: challenges and future prospects
    Das, Kallol
    Ayim, Benjamin Yaw
    Borodynko-Filas, Natasza
    Das, Srijan Chandra
    Aminuzzaman, F. M.
    JOURNAL OF PLANT PROTECTION RESEARCH, 2023, 63 (02) : 159 - 172
  • [33] CRISPR/Cas9 gene-editing platform corrects mutations associated with Duchenne muscular dystrophy
    Heather Wood
    Nature Reviews Neurology, 2015, 11 (4) : 184 - 184
  • [34] Correction of RNA splicing defect in β654-thalassemia mice using CRISPR/Cas9 gene-editing technology
    Lu, Dan
    Gong, Xiuli
    Fang, Yudan
    Guo, Xinbing
    Chen, Yanwen
    Yang, Fan
    Zhao, Guijun
    Ma, Qingwen
    Zeng, Yitao
    Zeng, Fanyi
    HAEMATOLOGICA, 2022, 107 (06) : 1427 - 1437
  • [35] Identifying novel targets for leukemia therapy using the CRISPR/Cas9 gene-editing tool
    Maeda, Takahiro
    CANCER SCIENCE, 2018, 109 : 810 - 810
  • [36] Applications of CRISPR/Cas gene-editing technology in yeast and fungi
    Binyou Liao
    Xi Chen
    Xuedong Zhou
    Yujie Zhou
    Yangyang Shi
    Xingchen Ye
    Min Liao
    Ziyi Zhou
    Lei Cheng
    Biao Ren
    Archives of Microbiology, 2022, 204
  • [37] CRISPR/Cas gene-editing technology and its advances in dentistry
    Alejandra Chavez-Granados, Patricia
    Manisekaran, Ravichandran
    Susana Acosta-Torres, Laura
    Garcia-Contreras, Rene
    BIOCHIMIE, 2022, 194 : 96 - 107
  • [38] In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges
    Mout, Rubul
    Ray, Moumita
    Lee, Yi-Wei
    Scaletti, Federica
    Rotello, Vincent M.
    BIOCONJUGATE CHEMISTRY, 2017, 28 (04) : 880 - 884
  • [39] A glance at genome editing with CRISPR–Cas9 technology
    Antara Barman
    Bornali Deb
    Supriyo Chakraborty
    Current Genetics, 2020, 66 : 447 - 462
  • [40] CRISPR/Cas9 Essential Gene Editing in Drosophila
    Osadchiy, I. S.
    Kamalyan, S. O.
    Tumashova, K. Y.
    Georgiev, P. G.
    Maksimenko, O. G.
    ACTA NATURAE, 2023, 15 (02): : 70 - 74
12345